GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: OMP-313M32
Compound class:
Antibody
Comment: Etigilimab (OMP-313M32) is an anti-TIGIT monoclonal antibody [1]. Blocking the TIGIT/PVR interaction is proposed to promote anti-tumour immunity. This mechanism is proposed to be used in conjunction with anti-PD/1/PD-L1 immuno-oncology therapeutics, to further enhance the anti-tumour immune response.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10742 | etigilimab |
Synonyms ![]() |
| OMP-313M32 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 803 |
| Other databases | |
| GtoPdb PubChem SID | 518520611 |
| Search PubMed clinical trials | etigilimab |
| Search PubMed titles | etigilimab |
| Search PubMed titles/abstracts | etigilimab |